Home › Companies › REGENERON PHARMACEUTICALS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and REGENERON PHARMACEUTICALS INC.’s Form 8-K, filed June 18, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 13, 2025: 9 items on REGENERON PHARMACEUTICALS INC.’s Form 8-K, filed June 18, 2025: 4 elected · 3 approved · 2 not approved.
Significant dissent: 1 director (27.3% against).
Notable dissent: 1 director (17.6% against); 1 other board item (19.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore REGENERON PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are REGENERON PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Bonnie L. Bassler, Ph.D. | 87,348,630 | 18,594,454 | 51,195 | -- | 5,601,648 | 82% | Elected | — |
| Elect Director: Michael S. Brown, M.D. | 77,025,558 | 28,913,874 | 54,847 | -- | 5,601,648 | 73% | Elected | — |
| Elect Director: Leonard S. Schleifer, M.D., Ph.D. | 99,271,439 | 6,672,701 | 50,139 | -- | 5,601,648 | 94% | Elected | — |
| Elect Director: George D. Yancopoulos, M.D., Ph.D. | 101,367,161 | 4,089,290 | 537,828 | -- | 5,601,648 | 96% | Elected | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 105,462,255 | 6,078,716 | 54,956 | -- | -- | 95% | Approved | — |
| 3. Advisory Vote on Executive Compensation The resolution to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's definitive proxy statement on Schedule 14A filed April 29, 2025 | 98,781,758 | 7,100,590 | 111,931 | -- | 5,601,648 | 93% | Approved | — |
| 4. Amendment to the Company's Certificate of Incorporation to Declassify the Board of Directors The proposal to amend the Company's Certificate of Incorporation to declassify the board of directors | 85,711,231 | 20,226,748 | 56,300 | -- | 5,601,648 | 81% | Approved | — |
| 5. Two Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal 5(a) – Amendment to Article IV, Section 2(e)(8) of the Company's Certificate of Incorporation Relating to the Mandatory Conversion of Class A | 85,490,681 | 2,279,384 | 142,814 | -- | 5,601,648 | 97% | Not approved Not approved: the filing states that this item needed more than a majority of the votes cast. | — |
| 5. Amendment to Article VI of the Company's Certificate of Incorporation Relating to the Removal of Directors for Cause The proposal to amend Article VI of the Company's Certificate of Incorporation, which required the affirmative vote of at least 80% of the o | 85,490,182 | 20,360,243 | 143,854 | -- | 5,601,648 | 81% | Not approved Not approved under the vote the filing states was required: “80% of the outstanding” | a supermajority of the shares outstanding |
Source: REGENERON PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 18, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
1,011 asset managers disclosed a vote on at least one REGENERON PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REGENERON PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Bonnie L. Bassler, Ph.D.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Bonnie L. Bassler, Ph.D.”): 87,348,630 for, 18,594,454 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The following nominees for Class I directors were elected to serve until the 2028 Annual Meeting of Shareholders and until their successors are duly elected and qualified based upon the following votes:”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 189 asset managers below reported 38,231,031 for, 2,473,441 against, 11,027 abstained, 337 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,981,262 | 18,602 | 0 | 0 | For |
| Fidelity | 7,844,889 | 18,906 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,379,046 | 3,632 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,262,773 | 552 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 33,502 | 431,426 | 0 | 0 | Mixed |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 248,143 | 3,850 | 0 | 0 | For |
| Dimensional | 0 | 198,787 | 0 | 0 | Against |
| ProShares | 0 | 184,041 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 106,974 | 52,474 | 0 | 0 | Mixed |
| First Trust | 0 | 158,161 | 0 | 0 | Against |
| Aberdeen | 0 | 156,122 | 0 | 0 | Against |
Showing the 25 largest of 189 asset managers. All 189 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael S. Brown, M.D.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michael S. Brown, M.D.”): 77,025,558 for, 28,913,874 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The following nominees for Class I directors were elected to serve until the 2028 Annual Meeting of Shareholders and until their successors are duly elected and qualified based upon the following votes:”
Support: 73% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 189 asset managers below reported 33,687,843 for, 7,016,628 against, 11,028 abstained, 337 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,980,004 | 19,860 | 0 | 0 | For |
| Fidelity | 5,712,127 | 2,151,668 | 0 | 0 | Mixed |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,378,444 | 4,234 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 2,143 | 1,261,182 | 0 | 0 | Against |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,016 | 107 | 0 | 0 | For |
| TIAA | 0 | 592,572 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 33,502 | 431,426 | 0 | 0 | Mixed |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 89,171 | 162,822 | 0 | 0 | Mixed |
| Dimensional | 0 | 198,787 | 0 | 0 | Against |
| ProShares | 0 | 184,041 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 106,974 | 52,474 | 0 | 0 | Mixed |
| First Trust | 0 | 158,161 | 0 | 0 | Against |
| Aberdeen | 0 | 156,122 | 0 | 0 | Against |
Showing the 25 largest of 189 asset managers. All 189 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Leonard S. Schleifer, M.D., Ph.D.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Leonard S. Schleifer, M.D., Ph.D.”): 99,271,439 for, 6,672,701 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The following nominees for Class I directors were elected to serve until the 2028 Annual Meeting of Shareholders and until their successors are duly elected and qualified based upon the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 189 asset managers below reported 40,603,849 for, 100,622 against, 11,027 abstained, 337 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,999,863 | 1 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,382,678 | 0 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,263,298 | 27 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
Showing the 25 largest of 189 asset managers. All 189 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: George D. Yancopoulos, M.D., Ph.D.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: George D. Yancopoulos, M.D., Ph.D.”): 101,367,161 for, 4,089,290 against, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The following nominees for Class I directors were elected to serve until the 2028 Annual Meeting of Shareholders and until their successors are duly elected and qualified based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 189 asset managers below reported 40,571,179 for, 133,257 against, 11,063 abstained, 337 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,998,606 | 1,257 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,381,991 | 687 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,263,298 | 27 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
Showing the 25 largest of 189 asset managers. All 189 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
81% Approved · of votes cast
Description as filed by funds: Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“4. Amendment to the Company's Certificate of Incorporation to Declassify the Board of Directors The proposal to amend the Company's Certificate of Incorporation to declassify the board of directors”): 85,711,231 for, 20,226,748 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 – Amendment to the Company's Certificate of Incorporation to Declassify the Board of Directors The proposal to amend the Company's Certificate of Incorporation to declassify the board of directors was approved based upon the following votes:”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 191 asset managers below reported 40,617,914 for, 27,386 against, 232 abstained, 337 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,999,864 | 0 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,382,678 | 0 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,263,325 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
Showing the 25 largest of 191 asset managers. All 191 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation
The 105 asset managers below reported 32,331,068 for, 5,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,997,219 | 0 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,263,325 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 144,124 | 0 | 0 | 0 | For |
| Thrivent | 135,053 | 0 | 0 | 0 | For |
| DWS | 123,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 109,808 | 0 | 0 | 0 | For |
| Pacific Life | 108,116 | 0 | 0 | 0 | For |
| Brighthouse | 104,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,606 | 0 | 0 | 0 | For |
Showing the 25 largest of 105 asset managers. All 105 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article VI of the Certificate of Incorporation.
The 105 asset managers below reported 32,331,068 for, 5,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,997,219 | 0 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,263,325 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 144,124 | 0 | 0 | 0 | For |
| Thrivent | 135,053 | 0 | 0 | 0 | For |
| DWS | 123,462 | 0 | 0 | 0 | For |
| Goldman Sachs | 109,808 | 0 | 0 | 0 | For |
| Pacific Life | 108,116 | 0 | 0 | 0 | For |
| Brighthouse | 104,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,606 | 0 | 0 | 0 | For |
Showing the 25 largest of 105 asset managers. All 105 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: PROPOSAL TO APPROVE AN AMENDMENT TO ARTICLE IV, SECTION 2(E)(8) OF THE CERTIFICATE OF INCORPORATION.
The 87 asset managers below reported 8,216,428 for, 4,086 against, 10 abstained, 337 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,380,859 | 1,819 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Russell Investments | 98,770 | 0 | 0 | 0 | For |
| Global X | 77,942 | 0 | 0 | 0 | For |
| Federated Hermes | 50,517 | 0 | 0 | 0 | For |
| John Hancock | 49,120 | 0 | 0 | 0 | For |
| Six Circles Trust | 41,096 | 0 | 0 | 0 | For |
| SEI | 31,231 | 0 | 0 | 0 | For |
| ETF Series Solutions | 31,019 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 30,403 | 0 | 0 | 0 | For |
| Prudential/PGIM | 25,221 | 0 | 0 | 0 | For |
| ADAMS DIVERSIFIED EQUITY FUND, INC. | 19,700 | 0 | 0 | 0 | For |
| NEOS ETF Trust | 18,244 | 0 | 0 | 0 | For |
| LAUDUS TRUST | 17,089 | 0 | 0 | 0 | For |
| Natixis | 16,717 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 15,208 | 0 | 0 | 0 | For |
| ARK ETF Trust | 13,352 | 0 | 0 | 0 | For |
| Calamos | 13,260 | 0 | 0 | 0 | For |
| Baird | 12,873 | 0 | 0 | 0 | For |
| World Funds Trust | 12,755 | 0 | 0 | 0 | For |
Showing the 25 largest of 87 asset managers. All 87 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
The 87 asset managers below reported 8,216,428 for, 4,086 against, 10 abstained, 337 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,380,859 | 1,819 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Russell Investments | 98,770 | 0 | 0 | 0 | For |
| Global X | 77,942 | 0 | 0 | 0 | For |
| Federated Hermes | 50,517 | 0 | 0 | 0 | For |
| John Hancock | 49,120 | 0 | 0 | 0 | For |
| Six Circles Trust | 41,096 | 0 | 0 | 0 | For |
| SEI | 31,231 | 0 | 0 | 0 | For |
| ETF Series Solutions | 31,019 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 30,403 | 0 | 0 | 0 | For |
| Prudential/PGIM | 25,221 | 0 | 0 | 0 | For |
| ADAMS DIVERSIFIED EQUITY FUND, INC. | 19,700 | 0 | 0 | 0 | For |
| NEOS ETF Trust | 18,244 | 0 | 0 | 0 | For |
| LAUDUS TRUST | 17,089 | 0 | 0 | 0 | For |
| Natixis | 16,717 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 15,208 | 0 | 0 | 0 | For |
| ARK ETF Trust | 13,352 | 0 | 0 | 0 | For |
| Calamos | 13,260 | 0 | 0 | 0 | For |
| Baird | 12,873 | 0 | 0 | 0 | For |
| World Funds Trust | 12,755 | 0 | 0 | 0 | For |
Showing the 25 largest of 87 asset managers. All 87 are in the interactive database (link above).
Combines 22 wordings of this item as funds reported it.
93% Approved · of votes cast
Prior year: 95.0% for (June 14, 2024 meeting) ▼ 1.7 pts
Description as filed by funds: Proposal to approve on an advisory basis executive compensation.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation The resolution to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's definitive proxy statement on Schedule ”): 98,781,758 for, 7,100,590 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Advisory Vote on Executive Compensation The resolution to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's definitive proxy statement on Schedule 14A filed April 29, 2025 was approved based upon the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,999,063 | 801 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,380,863 | 1,815 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,261,681 | 1,644 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
Fund voting reports, all 187 managers: 40,567,155 for, 47,029 against, 13,132 abstained, 337 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,933,557 | 0 | 0 | 0 | For |
| Capital Group | 5,877,428 | 1,880 | 0 | 0 | For |
| JPMorgan | 4,415,166 | 0 | 0 | 0 | For |
| BlackRock | 3,886,590 | 1,260 | 0 | 0 | For |
| State Street | 2,926,664 | 39,700 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,464,390 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,379,311 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,243,793 | 0 | 0 | 0 | For |
| Putnam | 1,912,289 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,310,590 | 44,934 | 0 | 0 | For |
| Amundi | 0 | 1,202,928 | 0 | 0 | Against |
| Northern Trust | 819,010 | 5,676 | 0 | 0 | For |
| Charles Schwab | 742,284 | 0 | 0 | 0 | For |
| Invesco | 695,231 | 0 | 0 | 0 | For |
| Vanguard | 667,591 | 0 | 0 | 0 | For |
| American Century | 638,926 | 0 | 0 | 0 | For |
| Nuveen | 616,062 | 0 | 0 | 0 | For |
| Two Sigma | 542,048 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 540,374 | 0 | 0 | 0 | For |
| AllianceBernstein | 518,893 | 0 | 0 | 0 | For |
| Neuberger Berman | 503,681 | 0 | 0 | 0 | For |
| UBS | 0 | 477,554 | 0 | 0 | Against |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 0 | 475,492 | 0 | 0 | Against |
| BNP Paribas Asset Management Holding S.A. | 0 | 463,850 | 0 | 0 | Against |
| Legal & General Investment Management Ltd | 13,175 | 448,100 | 0 | 0 | Against |
Institutional-manager reports, all 863 managers: 51,329,540 for, 5,200,301 against, 4,841 abstained, 7,680 not voted, 2,644 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 95.5% for (June 14, 2024 meeting) ▼ 0.9 pts
Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
REGENERON PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the ”): 105,462,255 for, 6,078,716 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved based upon the foll…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 193 asset managers below reported 40,600,474 for, 104,599 against, 11,027 abstained, 337 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,998,606 | 1,258 | 0 | 0 | For |
| Fidelity | 7,863,795 | 0 | 0 | 0 | For |
| Capital Group | 3,988,574 | 0 | 0 | 0 | For |
| BlackRock | 3,382,678 | 0 | 0 | 0 | For |
| JPMorgan | 2,188,086 | 0 | 0 | 0 | For |
| Dodge & Cox | 1,823,137 | 0 | 0 | 0 | For |
| Putnam | 1,369,593 | 0 | 0 | 0 | For |
| State Street | 1,263,298 | 27 | 0 | 0 | For |
| T. Rowe Price | 1,076,500 | 0 | 0 | 0 | For |
| AMCAP FUND | 803,406 | 0 | 0 | 0 | For |
| Charles Schwab | 700,123 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 482,472 | 0 | 0 | 0 | For |
| Victory Capital | 464,928 | 0 | 0 | 0 | For |
| American Century | 464,777 | 0 | 0 | 0 | For |
| Loomis Sayles | 421,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 384,525 | 0 | 0 | 0 | For |
| Invesco | 302,826 | 0 | 0 | 0 | For |
| Jackson National | 251,993 | 0 | 0 | 0 | For |
| Dimensional | 198,787 | 0 | 0 | 0 | For |
| ProShares | 184,041 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 173,159 | 0 | 0 | 0 | For |
| Equitable | 159,448 | 0 | 0 | 0 | For |
| First Trust | 158,161 | 0 | 0 | 0 | For |
| Aberdeen | 156,122 | 0 | 0 | 0 | For |
Showing the 25 largest of 193 asset managers. All 193 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of June 14, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 106,700,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.43% |
| 2 | Fidelity | 7.37% |
| 3 | Capital Group | 3.74% |
| 4 | BlackRock | 3.17% |
| 5 | JPMorgan | 2.05% |
| 6 | Dodge & Cox | 1.71% |
| 7 | Putnam | 1.28% |
| 8 | State Street | 1.18% |
| 9 | T. Rowe Price | 1.01% |
| 10 | AMCAP FUND | 0.75% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 6.50% |
| 2 | Capital Group | 5.51% |
| 3 | JPMorgan | 4.14% |
| 4 | BlackRock | 3.64% |
| 5 | State Street | 2.78% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.31% |
| 7 | T. Rowe Price | 2.23% |
| 8 | Dodge & Cox | 2.10% |
| 9 | Putnam | 1.79% |
| 10 | Loomis Sayles | 1.27% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| The Vanguard Group, Inc. | 8,838,240 | 8.28% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| BlackRock, Inc. | 8,629,707 | 8.09% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| State Street | 4,789,659 | 4.49% | Form 13F, quarter ended March 31, 2025 |
| JPMORGAN CHASE & CO. | 4,742,611 | 4.44% | Schedule 13G, filed June 5, 2025 |
| FMR LLC | 3,359,563 | 3.15% | Schedule 13G, filed August 6, 2025 |
| Geode Capital | 2,469,585 | 2.31% | Form 13F, quarter ended March 31, 2025 |
| Franklin Templeton | 2,276,675 | 2.13% | Form 13F, quarter ended March 31, 2025 |
| T. Rowe Price | 2,175,026 | 2.04% | Form 13F, quarter ended March 31, 2025 |
| Leonard S. Schleifer, M.D., Ph.D. | 1,725,565 | 1.62% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| Morgan Stanley | 1,250,954 | 1.17% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 106,700,000 shares outstanding, as reported by REGENERON PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At REGENERON PHARMACEUTICALS INC.'s shareholder meeting held June 13, 2025, in the 2024-2025 proxy season, 1,011 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 10,221 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Proposal to approve on an advisory basis executive compensation. — REGENERON PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: REGENERON PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENERON PHARMACEUTICALS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
REGENERON PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “REGENERON PHARMACEUTICALS (REGN) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/regeneron-pharmaceuticals-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.